shutterstock_151511186
Swiss pharmaceutical company Novartis has announced a collaboration with US-based biotech startup Rani Therapeutics to create a “robotic pill” that can deliver complex drugs which would usually be given with injections. The capsule is taken like a conventional pill, but contains tiny needles made of sugar that deliver drugs into the wall of the intestine. The approach could make the dream of delivering large-molecule biologic drugs in pill form possible. Most previous attempts have been stymied as the compounds are broken down in the stomach. The startup says it will be running feasibility studies over the next 18 to 24 months, evaluating which…

This story continues at The Next Web